Single Oral Dose of Bevenopran in Patients With Varying Degrees of Renal Impairment
Clinical trial NCT02508740 · TERMINATED
Trial details
- NCT number
- NCT02508740
- Sponsor
- Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2013-12-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.